Table 4.
Surveillance method | SSI | UTI | PN | LRI | BSI | CRI |
---|---|---|---|---|---|---|
RMCR (reference) | ||||||
Number of HAIs | 15 | 21 | 19 | 8 | 12 | 0 |
Prevalence of HAI episodes* (%) 95% CI |
1.0 (0.6-1.7) |
1.4 (0.9-2.2) |
1.3 (0.8-2.0) |
0.5 (0.3-1.1) |
0.8 (0.5-1.4) |
0 (0.0-0.3) |
SNHPS | ||||||
Number of HAIs | 15 | 20 | 26 | 7 | 13 | 0 |
Prevalence of HAI episodes* (%) 95% CI |
1.0 (0.6-1.7) |
1.4 (0.9-2.1) |
1.8 (1.2-2.6) |
0.5 (0.2-1.0) |
0.9 (0.5-1.5) |
0 (0.0-0.3) |
Sensitivity (%) 95% CI |
86.7 (59.5-98.3) |
76.2 (52.8-91.8) |
89.5 (66.9-98.7) |
62.5 (24.5-91.5) |
91.7 (61.5-99.8) |
/ |
Specificity (%) 95% CI |
99.9 (99.5-100) |
99.7 (99.3-99.9) |
99.4 (98.8-99.7) |
99.9 (99.5-100) |
99.9 (99.4-100) |
100 (99.8-100) |
Kappa coefficient 95% CI |
0.87 (0.74-1.00) |
0.78 (0.64-0.92) |
0.75 (0.61-0.89) |
0.67 (0.39-0.94) |
0.88 (0.74-1.00) |
/ |
on the day of SNHPS
SSI: surgical site infections. UTI: urinary tract infections. PN: pneumoniae. LRI: lower respiratory tract infections, excluding pneumoniae. BSI: bloodstream infections (including microbiologically proven catheter related infections). CRI: catheter-related infections without bloodstream infections. 95% CI: 95% confidence interval